KCa channel targeting impairs DNA repair and invasiveness of patient-derived glioblastoma stem cells in culture and orthotopic mouse xenografts which only in part is predictable by KCa expression levels.
Saved in:
| Title: | K |
|---|---|
| Authors: | Ganser K; Department of Radiation Oncology, University Hospital of Tübingen, Tübingen, Germany., Stransky N; Department of Radiation Oncology, University Hospital of Tübingen, Tübingen, Germany.; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany., Abed T; Department of Radiation Oncology, University Hospital of Tübingen, Tübingen, Germany., Quintanilla-Martinez L; Institute of Pathology and Neuropathology, Comprehensive Cancer Center, Eberhard Karls University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180), Image-Guided and Functionally Instructed Tumor Therapies, Eberhard Karls University, Tuebingen, Germany., Gonzalez-Menendez I; Institute of Pathology and Neuropathology, Comprehensive Cancer Center, Eberhard Karls University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180), Image-Guided and Functionally Instructed Tumor Therapies, Eberhard Karls University, Tuebingen, Germany., Naumann U; Molecular Neurooncology, Hertie Institute for Clinical Brain Research and Center Neurology, University of Tübingen, Tübingen, Germany., Koch P; Department of Pharmaceutical/Medicinal Chemistry II, Institute of Pharmacy, University of Regensburg, Regensburg, Germany., Krueger M; Department of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, University of Tübingen, Tübingen, Germany., Ruth P; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany., Huber SM; Department of Radiation Oncology, University Hospital of Tübingen, Tübingen, Germany., Eckert F; Department of Radiation Oncology, University Hospital of Tübingen, Tübingen, Germany.; Department of Radiation Oncology, Medical University Vienna, AKH, Comprehensive Cancer Center, Vienna, Austria. |
| Source: | International journal of cancer [Int J Cancer] 2024 Nov 15; Vol. 155 (10), pp. 1886-1901. Date of Electronic Publication: 2024 Jun 27. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38938062 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: K<subscript>Ca</subscript> channel targeting impairs DNA repair and invasiveness of patient-derived glioblastoma stem cells in culture and orthotopic mouse xenografts which only in part is predictable by K<subscript>Ca</subscript> expression levels. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ganser+K%22">Ganser K</searchLink>; Department of Radiation Oncology, University Hospital of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Stransky+N%22">Stransky N</searchLink>; Department of Radiation Oncology, University Hospital of Tübingen, Tübingen, Germany.; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Abed+T%22">Abed T</searchLink>; Department of Radiation Oncology, University Hospital of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Quintanilla-Martinez+L%22">Quintanilla-Martinez L</searchLink>; Institute of Pathology and Neuropathology, Comprehensive Cancer Center, Eberhard Karls University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180), Image-Guided and Functionally Instructed Tumor Therapies, Eberhard Karls University, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Menendez+I%22">Gonzalez-Menendez I</searchLink>; Institute of Pathology and Neuropathology, Comprehensive Cancer Center, Eberhard Karls University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180), Image-Guided and Functionally Instructed Tumor Therapies, Eberhard Karls University, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Naumann+U%22">Naumann U</searchLink>; Molecular Neurooncology, Hertie Institute for Clinical Brain Research and Center Neurology, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Koch+P%22">Koch P</searchLink>; Department of Pharmaceutical/Medicinal Chemistry II, Institute of Pharmacy, University of Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Krueger+M%22">Krueger M</searchLink>; Department of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Ruth+P%22">Ruth P</searchLink>; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Huber+SM%22">Huber SM</searchLink>; Department of Radiation Oncology, University Hospital of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Eckert+F%22">Eckert F</searchLink>; Department of Radiation Oncology, University Hospital of Tübingen, Tübingen, Germany.; Department of Radiation Oncology, Medical University Vienna, AKH, Comprehensive Cancer Center, Vienna, Austria. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220042124%22">International journal of cancer</searchLink> [Int J Cancer] 2024 Nov 15; Vol. 155 (10), pp. 1886-1901. <i>Date of Electronic Publication: </i>2024 Jun 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0042124 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0215 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200207136%22">00207136 </searchLink><i>NLM ISO Abbreviation: </i>Int J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38938062 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/ijc.35064 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1886 Titles: – TitleFull: KCa channel targeting impairs DNA repair and invasiveness of patient-derived glioblastoma stem cells in culture and orthotopic mouse xenografts which only in part is predictable by KCa expression levels. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ganser K – PersonEntity: Name: NameFull: Stransky N – PersonEntity: Name: NameFull: Abed T – PersonEntity: Name: NameFull: Quintanilla-Martinez L – PersonEntity: Name: NameFull: Gonzalez-Menendez I – PersonEntity: Name: NameFull: Naumann U – PersonEntity: Name: NameFull: Koch P – PersonEntity: Name: NameFull: Krueger M – PersonEntity: Name: NameFull: Ruth P – PersonEntity: Name: NameFull: Huber SM – PersonEntity: Name: NameFull: Eckert F IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 11 Text: 2024 Nov 15 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1097-0215 Numbering: – Type: volume Value: 155 – Type: issue Value: 10 Titles: – TitleFull: International journal of cancer Type: main |
| ResultId | 1 |